Glenmede Trust CO Na Lannett CO Inc Transaction History

Glenmede Trust CO Na

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $1,449 - $1,796	-252 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.43 - $9.86 $1,157 - $1,774	180 Added 250.0%	252 $1,000
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $401 - $1,041	72 New	72 $0

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.